Delivery Order SPE2DB25D3110-SPE2DB26FTCDT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,535.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 22, 2025, with completion targeted for August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a $1,020.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens (0.5 mL units) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a $5,734.19 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, representing one of many pharmaceutical products AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,417.72 on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a contract value of $3,903.90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity, a diabetes...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,488.88 on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This firm fixed-price contract, with a completion date of October 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order was awarded non-competitively as a competitively...
- The Defense Logistics Agency (DLA) awarded a $3,863.83 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award to the vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB26FTCDTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,096.22 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Trulicity is a diabetes management pharmaceutical, consistent with AmerisourceBergen's extensive portfolio of specialty medications supplied to federal medical procurement needs. This delivery order is issued under AmerisourceBergen's prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and related commodities to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's positioning as a major pharmaceutical distributor and DLA prime vendor reflects its capability to meet federal procurement requirements through competitive processes and deliver critical medical supplies across multiple therapeutic domains to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/27/25 |